Appier
Appier, a pioneer in Asia in cross screen marketing, helps businesses optimise advertising returns with their AI-driven solution by delivering the right ad to the right person at the right time across screens and ecosystems.
Notable Exits
WalkMe
WalkMe empowers companies in digital transformations with a cloud-based platform, providing visibility and enhancing user experiences for organisations to maximize software investments.
Motional
A pioneer in driverless automotive technology was a commercial spin-off from the cooperation between the National University of Singapore (NUS) and the Singapore-MIT Alliance for Research and Technology. In 2017, nuTonomy was acquired by Aptiv and later formed Motional in 2020 through a joint venture with Hyundai Motor.
Chartered Semiconductor
One of the world’s largest dedicated independent semiconductor foundries. Listed on NASDAQ and SGX in 1999 and acquired by Global Foundries in 2009.
Chartered Semiconductor Read More »
Coursera
Revolutionises online learning by providing universal access to the world’s best education through massive open online courses (MOOCs), as well as partnerships with top universities and organizations.
DocuSign
Digital Transaction Management platform that helps companies keep processes 100% digital from start to finish, accelerating transactions and reducing costs. Listed on Nasdaq in 2018.
Fluidigm
Now known as Standard BioTools Inc, Fluidigm’s technologies and products based on microfluidics and mass cytometry enable the exploration and analysis of individual cells, as well as the industrial application of genomics. Listed on NASDAQ in 2011.
Lonza
A large-scale cell culture manufacturing site for the production of monoclonal antibodies and recombinant proteins. Acquired by Lonza Group in 2008.
Moderna
Pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. Listed on NASDAQ in 2018.
